Commodore Capital Lp Top Holdings and 13F Report (2024) About Commodore Capital LpInvestment ActivityCommodore Capital Lp has $1.73 billion in total holdings as of June 30, 2024.Commodore Capital Lp owns shares of 36 different stocks, but just 17 companies or ETFs make up 80% of its holdings.Approximately 24.89% of the portfolio was purchased this quarter.About 26.97% of the portfolio was sold this quarter.This quarter, Commodore Capital Lp has purchased 33 new stocks and bought additional shares in 7 stocks.Commodore Capital Lp sold shares of 6 stocks and completely divested from 10 stocks this quarter.Largest Holdings Relay Therapeutics $169,150,000Alkermes $148,512,000Enliven Therapeutics $128,380,000Cogent Biosciences $111,159,389SPYRE THERAPEUTICS INC $96,460,447 Largest New Holdings this Quarter 29479A108 - Erasca $51,371,500 Holding36322Q206 - DAMORA THERAPEUTICS INC $50,220,100 Holding24477V105 - DEFINIUM THERAPEUTICS INC $37,800,000 Holding30233G209 - Eyepoint Pharmaceuticals $36,414,250 Holding221015100 - Corvus Pharmaceuticals $33,045,293 Holding Largest Purchases this Quarter Erasca 3,175,000 shares (about $51.37M)DAMORA THERAPEUTICS INC 1,939,000 shares (about $50.22M)DEFINIUM THERAPEUTICS INC 2,000,000 shares (about $37.80M)Eyepoint Pharmaceuticals 2,825,000 shares (about $36.41M)Corvus Pharmaceuticals 2,258,735 shares (about $33.05M) Largest Sales this Quarter Xenon Pharmaceuticals 975,000 shares (about $56.70M)Enliven Therapeutics 1,417,809 shares (about $55.58M)Tyra Biosciences 900,000 shares (about $34.47M)SPYRE THERAPEUTICS INC 475,865 shares (about $24.00M)Soleno Therapeutics 547,568 shares (about $18.33M) Sector Allocation Over TimeMap of 500 Largest Holdings ofCommodore Capital Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorRLAYRelay Therapeutics$169,150,0000.0%17,000,0009.8%MedicalALKSAlkermes$148,512,000$22,984,000 â–²18.3%4,200,0008.6%MedicalELVNEnliven Therapeutics$128,380,000$55,578,113 â–¼-30.2%3,275,0007.4%MedicalCOGTCogent Biosciences$111,159,389$26,602,825 â–²31.5%2,888,0076.4%MedicalSPYRE THERAPEUTICS INC$96,460,447$24,002,631 â–¼-19.9%1,912,3805.6%COM NEWTYRATyra Biosciences$94,792,500$34,470,000 â–¼-26.7%2,475,0005.5%MedicalCLDXCelldex Therapeutics$85,536,660$4,174,860 â–²5.1%2,696,6164.9%MedicalNUVLNuvalent$85,402,320$29,054,820 â–²51.6%833,6004.9%MedicalAMLXAmylyx Pharmaceuticals$78,535,0000.0%5,650,0004.5%MedicalKYMRKymera Therapeutics$62,467,5000.0%750,0003.6%MedicalALTO NEUROSCIENCE INC$61,217,446$20,232,000 â–²49.4%2,723,1963.5%COM SHSPHVSPharvaris$54,210,903$834,081 â–²1.6%1,918,9703.1%MedicalERASErasca$51,371,500$51,371,500 â–²New Holding3,175,0003.0%MedicalDAMORA THERAPEUTICS INC$50,220,100$50,220,100 â–²New Holding1,939,0002.9%COM NEWXENEXenon Pharmaceuticals$47,973,750$56,696,250 â–¼-54.2%825,0002.8%MedicalDEFINIUM THERAPEUTICS INC$37,800,000$37,800,000 â–²New Holding2,000,0002.2%COM SHSLB PHARMACEUTICALS INC$36,990,0000.0%1,500,0002.1%COM SHSEYPTEyepoint Pharmaceuticals$36,414,250$36,414,250 â–²New Holding2,825,0002.1%MedicalNRIXNurix Therapeutics$35,262,5000.0%2,275,0002.0%MedicalCRVSCorvus Pharmaceuticals$33,045,293$33,045,293 â–²New Holding2,258,7351.9%MedicalASSEMBLY BIOSCIENCES INC$27,750,0000.0%1,000,0001.6%COM NEWPERSPECTIVE THERAPEUTICS INC$26,424,381$26,424,381 â–²New Holding6,336,7821.5%COM NEWSLNOSoleno Therapeutics$21,843,423$18,332,576 â–¼-45.6%652,4321.3%MedicalOCULOcular Therapeutix$21,810,250$21,810,250 â–²New Holding2,575,0001.3%MedicalIPSCCentury Therapeutics$19,652,174$19,652,174 â–²New Holding8,695,6521.1%MedicalZURAZura Bio$19,337,500$19,337,500 â–²New Holding3,250,0001.1%MedicalSAB BIOTHERAPEUTICS INC$16,857,7450.0%4,401,5001.0%COM NEWPALISADE BIO INC$12,566,859$7,461,892 â–¼-37.3%7,181,0620.7%COMKARYOPHARM THERAPEUTICS INC$10,861,500$10,861,500 â–²New Holding1,950,0000.6%COM NEWINHIBIKASE THERAPEUTICS INC$9,067,7800.0%5,397,4880.5%COM NEWAN2 THERAPEUTICS INC$7,981,298$7,981,298 â–²New Holding2,333,7130.5%COMPEPGPepGen$7,920,750$1,902,750 â–²31.6%4,475,0000.5%MedicalAVALO THERAPEUTICS INC$7,211,1900.0%483,0000.4%COM NEWHELIX ACQUISITION CORP III$5,080,000$5,080,000 â–²New Holding500,0000.3%USD CL A ORD SHSLEONABIO INC$4,774,0110.0%464,3980.3%COMRLMDRelmada Therapeutics$4,411,951$4,411,951 â–²New Holding633,9010.3%MedicalTERNTerns Pharmaceuticals$0$59,590,000 â–¼-100.0%00.0%MedicalORUKA THERAPEUTICS INC$0$53,135,067 â–¼-100.0%00.0%COMPTGXProtagonist Therapeutics$0$39,303,000 â–¼-100.0%00.0%MedicalCTMXCytomX Therapeutics$0$32,769,198 â–¼-100.0%00.0%MedicalMNMDMind Medicine (MindMed)$0$26,780,000 â–¼-100.0%00.0%MedicalCNTACentessa Pharmaceuticals$0$25,010,000 â–¼-100.0%00.0%MedicalREPLReplimune Group$0$13,851,000 â–¼-100.0%00.0%MedicalCONTINEUM THERAPEUTICS INC$0$9,330,606 â–¼-100.0%00.0%CL ARAPT THERAPEUTICS INC$0$8,467,500 â–¼-100.0%00.0%COM NEWBRIGHT MINDS BIOSCIENCES INC$0$1,471,132 â–¼-100.0%00.0%COM NEWShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
